irasia.com - Investor Relations Asia Pacific
HOME

CSPC Pharmaceutical Group Limited
(Formerly known as China Pharmaceutical Group Limited)
(Incorporated in Hong Kong under the Companies Ordinance)

Announcements & Notices       


Please download the latest "Acrobat Reader" to view the PDF.

  • 2020-December-31
  • LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION (in PDF)
  • 2020-December-28
  • RESIGNATION OF NON-EXECUTIVE DIRECTOR AND INDEPENDENT NON-EXECUTIVE DIRECTOR, CHANGE OF COMPANY SECRETARY AND CHANGE OF BOARD COMMITTEES (in PDF)
  • 2020-December-28
  • INSIDE INFORMATION - ADJUSTMENT TO THE MEDICAL INSURANCE REIMBURSEMENT BASIS (in PDF)
  • 2020-December-18
  • Overseas Regulatory Announcement (Chinese version) (in PDF)
  • 2020-December-18
  • CONTINUING CONNECTED TRANSACTIONS - RENEWAL OF STEAM SUPPLY AGREEMENT (in PDF)
  • 2020-December-18
  • VOLUNTARY ANNOUNCEMENT - ABSTRACT OF CLINICAL TRIAL DATA OF MITOXANTRONE HYDROCHLORIDE LIPOSOME FOR RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA AND EXTRANODAL NK/T-CELL LYMPHOMA PRESENTED AT 2020 ASH ANNUAL MEETING (in PDF)
  • 2020-December-2
  • VOLUNTARY ANNOUNCEMENT - INVESTIGATIONAL NEW DRUG NBL-015 GRANTED ORPHAN-DRUG DESIGNATION BY THE U.S. FDA (in PDF)
  • 2020-December-1
  • VOLUNTARY ANNOUNCEMENT - INVESTIGATIONAL NEW DRUG "ALMB-0166" OBTAINS CLINICAL TRIAL APPROVAL IN CHINA (in PDF)
  • 2020-November-24
  • VOLUNTARY ANNOUNCEMENT - INVESTIGATIONAL FIRST-IN-CLASS PRODUCT SYSA1801 GRANTED ORPHAN-DRUG DESIGNATION BY THE U.S. FDA (in PDF)
  • 2020-November-24
  • LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION (in PDF)
  • 2020-November-23
  • APPOINTMENT OF EXECUTIVE DIRECTOR (in PDF)
  • 2020-November-23
  • QUARTERLY RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2020 (in PDF)
  • 2020-November-11
  • DATE OF BOARD MEETING (in PDF)
  • 2020-November-3
  • VOLUNTARY ANNOUNCEMENT - INNOVATIVE DRUG "SYHA1813 ORAL SOLUTIONS" OBTAINS CLINICAL TRIAL APPROVAL (in PDF)
  • 2020-October-28
  • VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN THE PHASE 1 CLINICAL TRIAL OF INVESTIGATIONAL NEW DRUG "ALMB-0168" (in PDF)
  • 2020-October-22
  • INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE THIRD QUARTER OF 2020 (in PDF)
  • 2020-October-12
  • POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON 12 OCTOBER 2020 (in PDF)
  • 2020-September-22
  • NOTICE OF EXTRAORDINARY GENERAL MEETING (in PDF)
  • 2020-September-17
  • VOLUNTARY ANNOUNCEMENT - "DOCETAXEL FOR INJECTION (ALBUMIN-BOUND)" OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S. (in PDF)
  • 2020-September-15
  • VOLUNTARY ANNOUNCEMENT - INVESTIGATIONAL NEW DRUG "ALMB-0168" OBTAINS CLINICAL TRIAL APPROVAL IN CHINA (in PDF)
  • 2020-August-28
  • CONTINUING CONNECTED TRANSACTIONS - RENEWAL OF STEAM SUPPLY AGREEMENT (in PDF)
  • 2020-August-26
  • 2020 INTERIM RESULTS ANNOUNCEMENT (in PDF)
  • 2020-August-25
  • VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW DRUG APPLICATION FOR "MITOXANTRONE HYDROCHLORIDE LIPOSOME INJECTION" (in PDF)
  • 2020-August-24
  • VOLUNTARY ANNOUNCEMENT - ONCOLOGY DRUG "SYHA1815 TABLETS" OBTAINS CLINICAL TRIAL APPROVAL (in PDF)
  • 2020-August-20
  • INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD . FOR THE HALF YEAR ENDED 30 JUNE 2020 (in PDF)
  • 2020-August-14
  • DATE OF BOARD MEETING (in PDF)
  • 2020-August-14
  • LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION (in PDF)
  • 2020-August-14
  • RESIGNATION OF DIRECTOR (in PDF)
  • 2020-July-27
  • VOLUNTARY ANNOUNCEMENT - "DULOXETINE HYDROCHLORIDE ENTERIC CAPSULES" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
  • 2020-July-21
  • VOLUNTARY ANNOUNCEMENT - "MEMANTINE HYDROCHLORIDE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
  • 2020-July-21
  • VOLUNTARY ANNOUNCEMENT - "ACARBOSE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
  • 2020-July-14
  • VOLUNTARY ANNOUNCEMENT - "CELECOXIB CAPSULES" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
  • 2020-June-23
  • VOLUNTARY ANNOUNCEMENT - "BORTEZOMIB FOR INJECTION" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
  • 2020-June-15
  • POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 15 JUNE 2020 (in PDF)
  • 2020-May-28
  • VOLUNTARY ANNOUNCEMENT - INNOVATIVE DRUG "SYHA1805" OBTAINS CLINICAL TRIAL APPROVAL (in PDF)
  • 2020-May-27
  • INSIDE INFORMATION - PROPOSED ISSUE OF RMB SHARES OR CHINESE DEPOSITARY RECEIPTS AND LISTING ON THE SCI-TECH BOARD OF THE SHANGHAI STOCK EXCHANGE (in PDF)
  • 2020-May-27
  • QUARTERLY RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2020 (in PDF)
  • 2020-May-19
  • VOLUNTARY ANNOUNCEMENT - "DOCETAXEL FOR INJECTION (ALBUMIN-BOUND)" OBTAINS CLINICAL TRIAL APPROVAL (in PDF)
  • 2020-May-15
  • DATE OF BOARD MEETING (in PDF)
  • 2020-May-4
  • VOLUNTARY ANNOUNCEMENT - "ORNITHINE ASPARTATE INJECTION" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
  • 2020-April-27
  • NOTICE OF ANNUAL GENERAL MEETING (in PDF)
  • 2020-April-26
  • INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE THREE MONTHS ENDED 31 MARCH 2020 (in PDF)
  • 2020-March-30
  • ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2019 (in PDF)
  • 2020-March-22
  • INSIDE INFORMATION - INDICATIVE RESULTS OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE THREE MONTHS ENDED 31 MARCH 2020 (in PDF)
  • 2020-March-22
  • INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE YEAR ENDED 31 DECEMBER 2019 (in PDF)
  • 2020-March-18
  • DATE OF BOARD MEETING (in PDF)
  • 2020-March-9
  • VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "RIVAROXABAN TABLETS" (in PDF)
  • 2020-February-25
  • VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "MONTELUKAST SODIUM TABLETS AND CHEWABLE TABLETS" (in PDF)
  • 2020-February-24
  • INSIDE INFORMATION - PRELIMINARY RESULTS OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE YEAR ENDED 31 DECEMBER 2019 (in PDF)
  • 2020-February-24
  • VOLUNTARY ANNOUNCEMENT - INVESTIGATIONAL NEW DRUG ALMB-0168 WAS GRANTED CLINICAL TRIAL APPROVAL IN AUSTRALIA (in PDF)
  • 2020-January-22
  • INSIDE INFORMATION - INDICATIVE RESULTS OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE YEAR ENDED 31 DECEMBER 2019 (in PDF)
  • 2020-January-19
  • VOLUNTARY ANNOUNCEMENT - SELECTION RESULTS OF NATIONAL CENTRALISED MEDICINES PROCUREMENT (in PDF)
  • 2020-January-2
  • VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "PRAMIPEXOLE DIHYDROCHLORIDE TABLETS" (in PDF)
  • 2020-January-2
  • VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "SUNITINIB MALATE CAPSULES" (in PDF)
  • 2022
  • 2022 Announcements & Notices
  • 2021
  • 2021 Announcements & Notices
  • 2019
  • 2019 Announcements & Notices
  • 2018
  • 2018 Announcements & Notices
  • 2017
  • 2017 Announcements & Notices
  • 2016
  • 2016 Announcements & Notices
  • 2015
  • 2015 Announcements & Notices
  • 2014
  • 2014 Announcements & Notices
  • 2013
  • 2013 Announcements & Notices
  • 2012
  • 2012 Announcements & Notices
  • 2011
  • 2011 Announcements & Notices
  • 2010
  • 2010 Announcements & Notices
  • 2009
  • 2009 Announcements & Notices
  • 2008
  • 2008 Announcements & Notices
  • 2007
  • 2007 Announcements & Notices
  • 2006
  • 2006 Announcements & Notices


  • Company's Index
  • irasia.com

  • About irasia.com   |   Terms of Use   |   Disclaimer
    © Copyright 1996-2022 irasia.com Ltd. All rights reserved.
    DISCLAIMER:
    irasia.com Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd. be liable for damages resulting from the use of the information provided on this website.